Jude Onyia, Chief Scientific Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 119,638 shares at $130.46 ($15.6M) on 2025-07-09, disclosed to the SEC on 2025-07-11.
Scheduled sale ($15.6M) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $130.46 | 59,819 | $7.8M | 50.0% |
| 2 | $130.46 | 59,819 | $7.8M | 50.0% |
| Total | $130.46 avg | 119,638 | $15.6M | 100% |
| Filing → |
| NBIX | SELL | 2025-07-07 | $5.3M | — | Filing → |
| NBIX | SELL | 2025-02-14 | $672K | — | Filing → |
| NBIX | SELL | 2025-02-04 | $19K | — | Filing → |